 The glucosamine sulfate substance used in this trial crystalline glucosamine sulfate is a prescription drug in Europe and elsewhere, mostly used in its 1500 mg powder for oral solution formulation to be administered once daily. This is the substanceformulation that was effective and safe in the vast majority of glucosamine clinical trials, including the long-term, 3-year studies. 